The absence of inflammation and vascular damage were also new findings, suggesting that chemotherapy and irradiation may require different protective strategies.
“The discovery of this syndrome of delayed degeneration was quite surprising, as were the transcriptional changes and the lack of repair,” Dr. Noble said. “It is vital that the neurology community increase their awareness of what a devastating problem this is for at least a subset of cancer patients.”
—Janis Kelly